Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

Details for Australian Patent Application No. 2009221327 (hide)

Owner Merck Patent GmbH

Inventors Kergoat, Micheline; Valeur, Eric; Charon, Christine; Botton, Gerard; Elbawab, Samer

Agent Davies Collison Cave

Pub. Number AU-A-2009221327

PCT Pub. Number WO2009/109258

Priority 08004053.8 05.03.08 EP

Filing date 15 January 2009

Wipo publication date 11 September 2009

International Classifications

C07D 241/44 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

28 October 2010 PCT application entered the National Phase

  PCT publication WO2009/109258 Priority application(s): WO2009/109258

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221328-Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

2009221324-Use of defensins against tuberculosis